Cellino
PrivateLast Round
Grant
Sep 10, 2024
Est. Valuation
$150M
Total Funding Raised
$125M
Company Overview
Cellino is a biotechnology company that develops an AI-guided laser editing platform to facilitate the scalable production of personalized autologous cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Medical AI, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellino Comparables
Compare Cellino with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Multiply Labs | 84% | |
| Ori Biotech | 78% | |
| Cellular Origins | 78% |
Cellino Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 10, 2024 | ||||
| Series A | Jan 25, 2022 | ||||
| Seed | Feb 1, 2021 | ||||
| Seed | Aug 9, 2019 |
Key People
Founding team and executive leadership
Cellino Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Series A, Seed |
| Engine Ventures | Series A, Seed |
| Khosla Ventures | Series A, Seed |
| Humboldt Fund | Seed, Series A |
| Engine Ventures | Seed |
| ARPA-H | Grant |
| 8VC | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Named to Fast Company's Most Innovative Companies list for 2026.
- Apr 15, 2025
Developing first Nebula-powered iPSC therapy for cardiovascular disease with Karis Bio.
Cellino Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellino's valuation, stock price, and market status.
Is Cellino a public or private company?
Cellino is a private company.
What is the current stock price of Cellino?
Cellino is a private company, so its shares have no public market price. Caplight tracks Cellino's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellino worth (valuation)?
Cellino's valuation is estimated at $150.0M based on funding round data.
Can I buy Cellino stock?
Cellino shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellino's last funding round?
Cellino's most recent funding round was Grant on September 10, 2024.
Who are the main investors in Cellino?
Key investors in Cellino include The Engine, Engine Ventures, Khosla Ventures, Humboldt Fund, Engine Ventures.
Will Cellino IPO soon?
No public IPO plans have been announced for Cellino.
How can I track Cellino secondary market activity?
Caplight tracks bids, offers, and trades in Cellino's shares on secondary markets.